In The News Posted January 2, 2020 Share Posted January 2, 2020 SANTA ROSA, Calif., Jan. 2, 2020 /PRNewswire/ -- Better Health Publishing—A multi-center Phase IIb clinical trial conducted in Israel, has been studying the effects of a dietary supplement, modified citrus pectin (PectaSol®, Econugenics, Santa Rosa, California) in prostate cancer patients... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.